Stimulants: epidemiology and impact on mental health

by Professor Fabrizio Schifano and Dr Antonio Albanese


Last updated: May 2015


Stimulants: epidemiology and impact on mental health

In the second half of the 1990s, a global trend of escalating stimulant misuse was observed across a number of EU countries (stimulants such as cocaine, amphetamine, methamphetamine, methylenedioxymethamphetamine/ MDMA, cathinone derivatives, benzylpiperazine/BZP).


When reorganising statutory and non-statutory services to cope with this increasingly widespread clinical issue, the epidemiological approach is of paramount importance, and a clear appreciation of the levels of stimulant misuse is necessary in order to allocate the appropriate levels of resources.


Stimulant misuse is typically associated with an imbalance of neurotransmitters, especially dopamine. Therefore, practising psychiatrists need to be aware of the psychopathological consequences related to substance misuse in order to refine their own diagnostic and clinical management skills.


Start the module



If you like this module, you may also be interested in:


Helping the addicted doctor by Dr Elizabeth Hare and Dr Malcolm Bruce


Substance misuse in older people by Dr Rahul Rao and Professor Ilana Crome


Drug Misuse: Psychosocial Interventions - The NICE Guideline (book from RCPsych publications)



BJPsych Advances: related articles for CPD Online



Related Advances articles


Download take-home notes to print and annotateDownload take-home notes to print and annotate


© 2016 Royal College of Psychiatrists